Axonics aspires to be the global leader in Sacral Neuromodulation by providing customer-centric solutions to treat urinary and bowel dysfunction and improve quality of life for patients and their families.
Axonics got Recognition in 2017 as One of FierceMedTech’s Fierce 15 Companies
Today: Axonics® Announces U.S. Food & Drug Administration Approval of Wireless Patient Remote Control with SmartMRI Technology